248 related articles for article (PubMed ID: 1754724)
1. Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
Acha-Orbea H
Res Immunol; 1991; 142(5-6):487-90. PubMed ID: 1754724
[TBL] [Abstract][Full Text] [Related]
2. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
3. Genetic and pathogenic basis of autoimmune diabetes in NOD mice.
Serreze DV; Leiter EH
Curr Opin Immunol; 1994 Dec; 6(6):900-6. PubMed ID: 7710714
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
5. T-cell autoimmunity in type 1 diabetes mellitus.
Birk OS; Cohen IR
Curr Opin Immunol; 1993 Dec; 5(6):903-9. PubMed ID: 8297523
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
7. A new look at MHC and autoimmune disease.
Ridgway WM; Fassò M; Fathman CG
Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
[No Abstract] [Full Text] [Related]
8. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
Nossal GJ; Herold KC; Goodnow CC
Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
[TBL] [Abstract][Full Text] [Related]
9. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
10. Failure in immune regulation begets IDDM in NOD mice.
Cameron MJ; Meagher C; Delovitch TL
Diabetes Metab Rev; 1998 Jun; 14(2):177-85. PubMed ID: 9679670
[TBL] [Abstract][Full Text] [Related]
11. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
12. Optimal T-cell receptor affinity for inducing autoimmunity.
Koehli S; Naeher D; Galati-Fournier V; Zehn D; Palmer E
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17248-53. PubMed ID: 25411315
[TBL] [Abstract][Full Text] [Related]
13. Adaptable TCR avidity thresholds for negative selection.
Stojakovic M; Salazar-Fontana LI; Tatari-Calderone Z; Badovinac VP; Santori FR; Kovalovsky D; Sant'Angelo D; Harty JT; Vukmanovic S
J Immunol; 2008 Nov; 181(10):6770-8. PubMed ID: 18981094
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular roles of beta cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes.
Yoon JW; Jun HS
Arch Pharm Res; 1999 Oct; 22(5):437-47. PubMed ID: 10549569
[TBL] [Abstract][Full Text] [Related]
15. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes.
Ridgway WM; Fathman CG
Clin Immunol Immunopathol; 1998 Jan; 86(1):3-10. PubMed ID: 9434791
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity--towards the year 2001.
Yeatman N; Sachs J; Bottazzo GF
Immunol Today; 1992 Jul; 13(7):239-40. PubMed ID: 1356343
[TBL] [Abstract][Full Text] [Related]
17. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
18. T cells with two functional antigen-specific receptors.
Hardardottir F; Baron JL; Janeway CA
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):354-8. PubMed ID: 7530361
[TBL] [Abstract][Full Text] [Related]
19. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
20. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
